Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6170654 | Contraception | 2016 | 7 Pages |
Abstract
Recent use of CHCs demonstrated significant changes in all four measured hepatic proteins at baseline compared to nonusers. Use of the NES/EE CVR further changed these hepatic protein markers, but values remained within the normal range. Prebaseline exposure to estrogen can obscure interpretation of hepatic proteins changes associated with a second CHC.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
D.F. Archer, M.A. Thomas, J. Conard, R.B. Merkatz, G.W. Creasy, K. Roberts, M. Plagianos, D. Blithe, R. Sitruk-Ware,